Neoadjuvant Nivolumab Plus Gemcitabine/Cisplatin Chemotherapy in Muscle-Invasive Urothelial Carcinoma of the Bladder
Cancer Research and Treatment. 2023;55(2):636-642 
Commentary on A role for neoadjuvant gemcitabine plus cisplatin in muscle-invasive urothelial carcinoma of the bladder: A retrospective experience
Urologic Oncology: Seminars and Original Investigations. 2009;27(3):338
Neoadjuvant chemotherapy with gemcitabine and cisplatin followed by selective bladder preservation chemoradiotherapy in muscle-invasive urothelial carcinoma of bladder
Investigative and Clinical Urology. 2022;63(2):168
A role for neoadjuvant gemcitabine plus cisplatin in muscle-invasive urothelial carcinoma of the bladder
Cancer. 2008;113(9):2471-2477
Neoadjuvant Chemotherapy in Muscle Invasive Urothelial Bladder Cancer
Robotic Urology. 2018;241-248
Neoadjuvant chemotherapy with gemcitabine/cisplatin vs. methotrexate/vinblastine/doxorubicin/cisplatin for muscle-invasive urothelial carcinoma of the bladder: A retrospective analysis from the University of Southern California
Urologic Oncology: Seminars and Original Investigations. 2013;31(8):1737-1743
Comparison between neoadjuvant and adjuvant gemcitabine plus cisplatin chemotherapy for muscle‐invasive bladder cancer
Asia-Pacific Journal of Clinical Oncology. 2012;9(4):310-317
Muscle-Invasive Urothelial Carcinoma of the Bladder: Neoadjuvant Chemotherapy Enables Organ-Preserving Therapy in Carefully Selected Patients
European Urology. 2008;54(1):21-23
Conservative treatment in patients with muscle-invasive bladder cancer by transurethral resection, neoadjuvant chemotherapy with gemcitabine and cisplatin, and accelerated radiotherapy with concomitant boost plus concurrent cisplatin – assessment of response and toxicity.
Reports of Practical Oncology & Radiotherapy. 2008;13(6):300-308
Pathologic Response Rates of Gemcitabine/Cisplatin versus Methotrexate/Vinblastine/Adriamycin/Cisplatin Neoadjuvant Chemotherapy for Muscle Invasive Urothelial Bladder Cancer
Advances in Urology. 2013;2013:1-6